Pipeline

Progress of Programs

Stage
Jun 30, 2017
Sep 30, 2017
Dec 31, 2017
Mar 31, 2018
Number of Ongoing Programs
60 68 82 83
Hit-to-Lead Stage
23 24 29 33
Lead-to-Preclinical
8 8 8 8
Clinical Candidates
3 3 3 4
Phase 1 Clinical Study
1 1 1 2
Phase 2 Clinical Study
0 0 0 0
Phase 3 Clinical Study
0 0 0 0